Tag: Dicerna Pharmaceuticals

September 25, 2019 Off

Dicerna™ to Present at Two Upcoming Investor Conferences

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…

May 3, 2019 Off

Dicerna approves purchase of 145,500 shares of common stock to bedistributed among eight new employees

By BusinessWire

Dicerna Pharmaceuticals Board of Directors approved the grant of inducement stockoptions to purchase a total of 145,500 shares of common stock to bedistributed among eight new employees